Author
Listed:
- Qilong Wang
(Louisville Veterans Administration Medical Center
James Brown Cancer Center, University of Louisville, CTRB 309, 505 Hancock Street, Louisville, Kentucky 40202, USA)
- Xiaoying Zhuang
(James Brown Cancer Center, University of Louisville, CTRB 309, 505 Hancock Street, Louisville, Kentucky 40202, USA)
- Jingyao Mu
(James Brown Cancer Center, University of Louisville, CTRB 309, 505 Hancock Street, Louisville, Kentucky 40202, USA)
- Zhong-Bin Deng
(University of Louisville)
- Hong Jiang
(Louisville Veterans Administration Medical Center
James Brown Cancer Center, University of Louisville, CTRB 309, 505 Hancock Street, Louisville, Kentucky 40202, USA)
- Lifeng Zhang
(James Brown Cancer Center, University of Louisville, CTRB 309, 505 Hancock Street, Louisville, Kentucky 40202, USA)
- Xiaoyu Xiang
(James Brown Cancer Center, University of Louisville, CTRB 309, 505 Hancock Street, Louisville, Kentucky 40202, USA)
- Baomei Wang
(James Brown Cancer Center, University of Louisville, CTRB 309, 505 Hancock Street, Louisville, Kentucky 40202, USA)
- Jun Yan
(University of Louisville)
- Donald Miller
(University of Louisville)
- Huang-Ge Zhang
(Louisville Veterans Administration Medical Center
James Brown Cancer Center, University of Louisville, CTRB 309, 505 Hancock Street, Louisville, Kentucky 40202, USA)
Abstract
Although the use of nanotechnology for the delivery of a wide range of medical treatments has potential to reduce adverse effects associated with drug therapy, tissue-specific delivery remains challenging. Here we show that nanoparticles made of grapefruit-derived lipids, which we call grapefruit-derived nanovectors, can deliver chemotherapeutic agents, short interfering RNA, DNA expression vectors and proteins to different types of cells. We demonstrate the in vivo targeting specificity of grapefruit-derived nanovectors by co-delivering therapeutic agents with folic acid, which in turn leads to significantly increasing targeting efficiency to cells expressing folate receptors. The therapeutic potential of grapefruit-derived nanovectors was further demonstrated by enhancing the chemotherapeutic inhibition of tumour growth in two tumour animal models. Grapefruit-derived nanovectors are less toxic than nanoparticles made of synthetic lipids and, when injected intravenously into pregnant mice, do not pass the placental barrier, suggesting that they may be a useful tool for drug delivery.
Suggested Citation
Qilong Wang & Xiaoying Zhuang & Jingyao Mu & Zhong-Bin Deng & Hong Jiang & Lifeng Zhang & Xiaoyu Xiang & Baomei Wang & Jun Yan & Donald Miller & Huang-Ge Zhang, 2013.
"Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids,"
Nature Communications, Nature, vol. 4(1), pages 1-13, October.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2886
DOI: 10.1038/ncomms2886
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2886. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.